Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Faron appoints Birge Berns as interim medical officer

Thu, 21st Sep 2023 12:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company - Appoints Birge Berns as interim chief medical officer. Berns will be based in the UK and will start on Friday. She is a pharmaceuticals executive with a background in oncology, clinical medicine, rheumatology and immunology. Berns succeeds outgoing CMO Marie-Louise Fjallskog, who is stepping down but will be proposed as a non-executive director at Faron's extraordinary general meeting on Friday. In this new role, Fjallskog would continue to be involved in the development of Faron's wholly owned immunotherapy asset, bexmarilimab.

----------

Molecular Energies PLC - Argentina and US-focused oil and gas production company - Updates investors ahead of general meeting being held later on Thursday to approve the sale of the entire issued share capital of President Energy Holding UK Ltd. Says the team has been evaluating alternative major energy projects, with a focus on sustainable aviation fuel. Adds that it has started feasibility planning for the industrial scale production of this fuel, noting that while its work is at a preliminary stage, it has already signed several non-disclosure agreements with potential stakeholders and relevant partners with whom it enjoys established relationships. Further, says that its exploration well in Paraguay is now expected to spud at or around the end this month or the first week of October. The rig mast has been erected and rig testing is now commencing with the repaired blow-out preventer after final testing currently now scheduled for delivery at the end of September.

----------

Mercia Asset Management PLC - Warwickshire, England-based specialist asset manager - Non-Executive Chair Ian Metcalfe tells annual general meeting on Thursday that the company has made a "positive start" to the current financial year. "The group remains well placed to support existing funds' portfolio companies, as well as adding new investments to those portfolios as a result of our continuing group-wide liquidity position and strong deal origination capabilities," he says. "We remain optimistic for continuing progress across the group during the second half of the current financial year."

----------

StreaksAI PLC - London-based provider of artificial intelligence-based conversational technologies - Launches Streaks Idols, a social product and artificial intelligence character generator which offers a range of customisable AI-powered chatbots capable of sophisticated humanlike interaction. Says the chatbot can respond to text and voice prompts, with video prompts currently under development. Adds that it is a mass-market product that will enable the general public to generate their own AI characters with innate monetisation, allowing creators to generate revenue as users engage with their online personas.

----------

88 Energy Ltd - Subiaco, Western Australia-based oil and gas company - Says mapping of recently identified upper slope fan system across its Project Phoenix acreage on the central North Slope of Alaska has been finalised. Seismic interpretation and log correlation has revealed that the reservoir is more extensive than originally mapped, correlating over four miles to strong shows in the Icewine-1 well. Resources in this reservoir are not currently included in the company's resource estimates as they have yet to be assessed. Notes that the quality and strength of shows recorded during the drilling and logging of Hickory-1 remain "amongst the best the company has witnessed to date". Moreover, says post-well geochemical analysis of Hickory-1 sidewall core data indicates fluid maturity to be in the early-peak oil window.

----------

Filtronic PLC - Sedgefield, England-based designer and manufacturer of products and sub-systems for the aerospace, defence, telecoms infrastructure, space, and critical communications markets - Inks contract with global provider of low earth orbit satellite communications equipment. The contract is valued at USD4.3 million, with revenue expected to be recognised in financial 2024, is for the supply of Filtronic's innovative Cerus32 solid state power amplifier module combined with a customised control board. The SSPA modules will be installed in selected ground station locations for the second phase of the customer's earth station antenna deployment which is designed to provide full E-band connectivity to recently launched E-band enabled LEO satellites.

----------

Trakm8 Holdings PLC - Birmingham, England-based telematics and data insight provider - Executive Chair John Watkins says that the financial year has started in line with management's expectations and that Fleet and Optimisation revenues have been ahead of last year. However, as anticipated, Insurance revenue continues to be suppressed because of the capacity constraints in the Insurance market that have persisted, though the addition of two new customers recently has provided some mitigation to this. In the first five months of the current financial year, new unit sales fell 28% to 63,402 from 87,362 a year prior. Total total connections have reduced overall by approximately 6% to 326,000. The firm now expects revenue for the six months ending September 30 to be "slightly lower" than last year's. It originally expected that during the second half of the current financial year the capacity issues would ease. However, it now believes that the downside risk of these challenges may continue for the remainder of the financial year.

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 13:39

TRADING UPDATES: Kelso raises stake in NCC; Transense joins project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

Read more
30 Apr 2024 16:33

Faron Pharmaceuticals extends funding agreement with IPF

(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support as it progressed towards securing longer-term funding.

Read more
15 Apr 2024 10:58

Faron Pharmaceuticals reappoints former finance chief on interim basis

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien.

Read more
15 Apr 2024 09:36

Faron Pharmaceuticals CFO stands down

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".

Read more
8 Apr 2024 11:50

UPDATE: Faron Pharmaceuticals promotes COO to CEO as father retires

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace his father, the company's founder.

Read more
8 Apr 2024 11:28

Faron Pharmaceuticals promotes COO to CEO as founder steps back

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace the company's founder.

Read more
8 Apr 2024 09:17

Faron Pharmaceuticals taps Juho Jalkanen for CEO

(Sharecast News) - Biopharmaceutical company Faron Pharmaceuticals named Dr Juho Jalkanen as its next chief executive officer on Monday.

Read more
4 Apr 2024 11:58

Faron Pharmaceuticals secures funding to deliver next "milestones"

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has successfully raised funds to support the phase two study of its bexmarilimab cancer treatment.

Read more
3 Apr 2024 10:59

TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Apr 2024 13:22

UK shareholder meetings calendar - next 7 days

Wednesday 3 April 
Downing Strategic Micro-Cap Investment Trust PLCGM re approval of B share scheme
Quantum Exponential Group PLCGM re delisting or potential investment in company
Thursday 4 April 
Rio Tinto PLCAGM
Scottish American Investment Co PLCAGM
TheWorks.co.uk PLCGM re Main Market delisting and AIM admission
Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 17:09

LONDON MARKET CLOSE: Stocks downbeat before central bank rate storm

(Alliance News) - Stocks in London closed in the red on Monday, as tech gains in New York failed to make an impact ahead of several interest rate decisions from central banks across the world this week.

Read more
18 Mar 2024 14:14

Faron shares jump on encouraging trial data

(Sharecast News) - Faron Pharmaceuticals announced further encouraging data from the first phase of its 'BEXMAB' trial on Monday, targeting higher-risk (HR) myelodysplastic syndrome (MDS) patients who had failed prior hypomethylating agent (HMA) treatment.

Read more
18 Mar 2024 11:41

Faron Pharmaceuticals shares jump on positive data from Bexmab study

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said a study showed more patients responding to treatment in a new readout of the Bexmab study focused on myelodysplastic syndrome, or MDS.

Read more
18 Mar 2024 10:05

AIM WINNERS & LOSERS: Clontarf raises GBP400,000; Faron jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.